Protein SSX2 (41-49)

Protein SSX2 (41-49) is a synthetic peptide fragment corresponding to amino acids 41 through 49 of the SSX2 protein, a member of the synovial sarcoma X breakpoint protein family. As a short linear peptide, it serves as a valuable tool for researchers investigating protein-protein interactions, post-translational modifications, and immune recognition mechanisms related to SSX2. The unique sequence of this peptide enables the study of SSX2's functional domains, particularly those implicated in cellular signaling and gene regulation. Its defined structure and origin from a cancer-testis antigen further enhance its significance in molecular biology and immunology research.

Epitope mapping: Utilization of the SSX2 (41-49) peptide is instrumental in mapping immunogenic epitopes within the SSX2 protein. By providing a well-defined sequence, it allows researchers to delineate antibody binding sites or T-cell receptor recognition motifs, supporting the identification of immunologically relevant regions. This application is particularly important in the context of understanding antigen presentation and advancing the design of immunological assays, such as ELISPOT or MHC tetramer staining, that rely on precise peptide epitopes.

Peptide-based assay development: The fragment is routinely employed as a standard or substrate in the development and optimization of peptide-specific detection assays. Its stable, synthetic nature ensures reproducibility in binding or enzymatic assays, supporting the quantification of SSX2-specific immune responses or the activity of peptide-processing enzymes. Such assays are vital for validating antibody specificity, screening for peptide-MHC interactions, and assessing peptide cleavage or modification events in vitro.

Protein-protein interaction studies: As a representative segment of the SSX2 protein, the 41-49 peptide is valuable for dissecting short linear motif-mediated interactions. Researchers utilize it to probe binding partners, characterize interaction affinities, and map minimal binding domains within larger protein complexes. This approach facilitates mechanistic studies of SSX2's role in cellular pathways, such as transcriptional regulation or chromatin remodeling, by isolating the contribution of specific sequence motifs.

T-cell activation research: The SSX2 (41-49) peptide is frequently used to stimulate T cells in vitro, enabling the assessment of antigen-specific cellular immune responses. By presenting the peptide via major histocompatibility complex (MHC) molecules on antigen-presenting cells, investigators can evaluate T-cell activation, cytokine release, and proliferation. These studies provide insights into the immunogenicity of SSX2-derived sequences and inform the development of peptide-based immunological tools for basic research applications.

Structure-function analysis: Incorporation of the SSX2 (41-49) peptide into structure-activity relationship studies supports the elucidation of sequence determinants underlying SSX2's biological activity. By systematically modifying residues within the peptide, researchers can assess the impact on binding, recognition, or functional output, contributing to a deeper understanding of how discrete regions of the SSX2 protein influence its molecular interactions and regulatory roles. This strategy is essential for advancing knowledge of peptide-mediated signaling and protein domain functionality.

1. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

2. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I